GoldenGolden
Advanced Search
Psoriasis

Psoriasis

Human disease

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
April 23, 2021
BioSpace
The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis - read this article along with other careers information, tips and advice on BioSpace
UCB, Inc.
April 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- UCB, a global biopharmaceutical company, announced today that The New England Journal of Medicine has published two manuscripts with results...
Innovent Biologics
December 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high...
BioSpace
November 16, 2020
BioSpace
Weill Cornell Medicine's Dr. Richard Granstein, M.D., Chairman of Dermatology, will collaborate with Biohaven to study a Calcitonin Gene-Related Peptide (CGRP) receptor-antagonist in plaque psoriasis
September 30, 2019
Deccan Chronicle
Psoriasis often develops between 15 and 35 years, but it can develop at any age.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.